Literature DB >> 29462781

Tripolyphosphate-crosslinked chitosan/poly (ethylene oxide) electrospun nanofibrous mats as a floating gastro-retentive delivery system for ranitidine hydrochloride.

Behzad Darbasizadeh1, Hamidreza Motasadizadeh2, Behrouz Foroughi-Nia3, Hassan Farhadnejad4.   

Abstract

The present study describes the fabrication of Tripolyphosphate (TPP)-crosslinked nanofibrous mats based on chitosan for use as a floating gastro-retentive delivery system. TPP-crosslinked chitosan (CH)/poly (ethylene oxide) (PEO)- ranitidine hydrochloride (RH) electrospun nanofibers (75.27 ± 2.10 nm) were prepared by electrospinning 70% v/v acetic acid solutions, and followed by crosslinking by TPP anions. The mechanical, structural and morphological properties of the prepared nanofibers were evaluated via tensile testing, XRD, FT-IR, TGA, NMR, AFM and SEM experimental techniques. The prepared nanofibrous mats showed a pH sensitive swelling profile with maximum water absorbing at pH 1.2. Results obtained from above experimental techniques indicated that crosslinking process did not significantly altered morphological property of nanofibers but rather decreased their diameter and swelling degree, and increased their mechanical properties, thermal stability and bioadhesive strength. Viscosity measurements showed that the addition of PEO and RH to the chitosan solution, depending to its concentration lead to decrease in the viscosity of its solution. Also, floating test showed that the prepared nanofibrous mats remain floated onto surface of the dissolution medium for more than 48 h. Based on in- vitro drug release data analysis, TPP-crosslinked CH/PEO nanofibrous mats decreased initial burst release and it was exhibited a sustained release profile for the RH from the TPP-crosslinked CH/PEO-RH electrospun nanofibrous mats.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chitosan; Crosslinking; Electrospinning; Floating drug delivery; PEO

Mesh:

Substances:

Year:  2018        PMID: 29462781     DOI: 10.1016/j.jpba.2018.02.023

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  7 in total

Review 1.  Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review.

Authors:  Paola Mura; Francesca Maestrelli; Marzia Cirri; Natascia Mennini
Journal:  Mar Drugs       Date:  2022-05-20       Impact factor: 6.085

Review 2.  Gastro-retentive drug delivery systems: a recent update on clinical pertinence and drug delivery.

Authors:  Supratim Das; Sukhbir Kaur; Vineet Kumar Rai
Journal:  Drug Deliv Transl Res       Date:  2021-01-05       Impact factor: 4.617

Review 3.  Recent Biomedical Approaches for Chitosan Based Materials as Drug Delivery Nanocarriers.

Authors:  Andreea Teodora Iacob; Florentina Geanina Lupascu; Maria Apotrosoaei; Ioana Mirela Vasincu; Roxana Georgiana Tauser; Dan Lupascu; Simona Eliza Giusca; Irina-Draga Caruntu; Lenuta Profire
Journal:  Pharmaceutics       Date:  2021-04-20       Impact factor: 6.321

4.  Fabrication of polytetrafluoroethylene nanofibrous membranes for guided bone regeneration.

Authors:  Jin-Young Park; Jung-Hee Lee; Chun-Ho Kim; Young-Jin Kim
Journal:  RSC Adv       Date:  2018-10-08       Impact factor: 3.361

5.  Montmorillonite-Famotidine/Chitosan Bio-nanocomposite Hydrogels as a Mucoadhesive/Gastroretentive Drug Delivery System.

Authors:  Hassan Farhadnejad; Seyed Alireza Mortazavi; Sanaz Jamshidfar; Amir Rakhshani; Hamidreza Motasadizadeh; Yousef Fatahi; Athar Mahdieh; Behzad Darbasizadeh
Journal:  Iran J Pharm Res       Date:  2022-05-12       Impact factor: 1.962

6.  Highlighting the impact of chitosan on the development of gastroretentive drug delivery systems.

Authors:  Maurício Palmeira Chaves de Souza; Rafael Miguel Sábio; Tais de Cassia Ribeiro; Aline Martins Dos Santos; Andréia Bagliotti Meneguin; Marlus Chorilli
Journal:  Int J Biol Macromol       Date:  2020-05-18       Impact factor: 8.025

7.  Glutaraldehyde-crosslinked chitosan-polyethylene oxide nanofibers as a potential gastroretentive delivery system of nizatidine for augmented gastroprotective activity.

Authors:  Walaa Ebrahim Abd El Hady; Osama Abd El-Aazeem Soliman; Hassan Mohamed El Sabbagh; Elham Abdelmonem Mohamed
Journal:  Drug Deliv       Date:  2021-08-24       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.